Adjusted* chlamydia prevalence (%) among participants according to selected variables
| Men | n/N | N | Women | n/N | N | Total | n/N | N | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prev (95% CI) | UW | WT | p Value | Prev (95% CI) | UW | WT | p Value | Prev (95% CI) | UW | WT | p Value | |
| *Adjusted prevalence: inverse probability weighted for age/sex/AAD (see Methods). | ||||||||||||
| †Likelihood ratio test in univariate logistic regression. | ||||||||||||
| ‡Symptoms in men: pain in passing urine, more frequent urination and/or penile discharge. Symptoms in women: intermenstrual or postcoital bleeding, abnormal vaginal discharge, pain in passing urine, frequent urination and/or lower abdominal pain. | ||||||||||||
| ¶Only if sexually active (ever). | ||||||||||||
| Missing values reduce the denominator in several categories. | ||||||||||||
| n/N, number of positives among total participants with information on this variable; UW, unweighted; WT, weighted. | ||||||||||||
| Overall | 1.5 (1.1–1.8) | 43/2918 | 4228 | 2.5 (2.0–3.0) | 122/5421 | 4111 | 2.0 (1.7–2.3) | 165/8339 | 8339 | <0.001 | ||
| Ethnicity | 0.052 | <0.001 | <0.001 | |||||||||
| Dutch | 1.4 (1.0–1.8) | 36/2608 | 3759 | 2.2 (1.7–2.7) | 98/4908 | 3688 | 1.8 (1.5–2.1) | 134/7516 | 7446 | |||
| Suriname/Antilleans | 4.4 (0.0–9.3) | 2/43 | 68 | 12.1 (5.4–18.8) | 13/104 | 91 | 8.2 (3.9–12.5) | 15/147 | 158 | |||
| Turkish/Moroccan | 6.3 (1.0–11.7) | 3/50 | 79 | 1.2 (0.0–3.6) | 1/97 | 82 | 3.1 (0.4–5.8) | 4/147 | 160 | |||
| Other | 1.4 (0.0–3.0) | 2/142 | 213 | 3.3 (0.7–5.8) | 7/229 | 184 | 2.3 (0.8–3.7) | 9/371 | 397 | |||
| Education | 0.001 | 0.004 | <0.001 | |||||||||
| Low | 2.5 (1.6–3.3) | 21/859 | 1257 | 3.6 (2.4–4.7) | 40/1234 | 956 | 2.9 (2.2–3.6) | 61/2093 | 2214 | |||
| Intermediate | 1.5 (0.9–2.1) | 16/1124 | 1579 | 2.6 (1.8–3.3) | 53/2270 | 1670 | 2.1 (1.6–2.6) | 69/3394 | 3250 | |||
| High | 0.6 (0.2–1.1) | 6/832 | 1243 | 1.5 (0.8–2.1) | 24/1754 | 1359 | 1.1 (0.7–1.5) | 30/2586 | 2602 | |||
| Symptoms‡ | <0.001 | <0.001 | <0.001 | |||||||||
| Yes | 5.2 (2.8–7.7) | 10/218 | 325 | 3.8 (2.8–4.8) | 67/1978 | 1527 | 4.0 (3.1–4.9) | 77/2196 | 1851 | |||
| No | 1.2 (0.8–1.5) | 33/2700 | 3904 | 1.7 (1.2–2.2) | 55/3443 | 2584 | 1.4 (1.1–1.7) | 88/6143 | 6488 | |||
| Sexually active | 0.001 | <0.001 | <0.001 | |||||||||
| Yes | 1.8 (1.3–2.2) | 41/2317 | 3354 | 2.8 (2.3–3.4) | 119/4688 | 3550 | 2.3 (2.0–2.7) | 160/7005 | 6904 | |||
| No | 0.4 (0.0–0.8) | 2/525 | 760 | 0.2 (0.0–0.6) | 1/654 | 499 | 0.3 (0.0–0.6) | 3/1179 | 1259 | |||
| Number lifetime partners¶ | <0.001 | <0.001 | <0.001 | |||||||||
| 1 | 0.5 (0.1–0.9) | 5/716 | 1007 | 0.6 (0.2–1.0) | 10/1829 | 1345 | 0.6 (0.3–0.9) | 15/2545 | 2353 | |||
| 2–5 | 1.3 (0.7–1.9) | 13/1057 | 1518 | 2.9 (2.1–3.8) | 58/2200 | 1667 | 2.1 (1.6–2.6) | 71/3257 | 3184 | |||
| ⩾6 | 4.1 (2.7–5.5) | 21/518 | 784 | 8.0 (5.6–10.3) | 49/625 | 514 | 5.6 (4.4–6.9) | 70/1143 | 1298 | |||